-The Telegraph New Delhi: The Supreme Court has declined to entertain a plea that women be allowed to medically terminate pregnancy after the 20-week deadline fixed by law as many carry foetuses with abnormalities in the last trimester. A bench of Justices S.J. Mukhopadhyaya and Kurien Joseph declined to pass any order on the plea and instead allowed counsel Divya Jyothi to withdraw the petition with liberty to come out with an...

-The Hindu Hyderabad: The road to motherhood is fraught with risks for women visiting the two government maternity hospitals in the city, says a recent study by women's group ‘Stree Vimukti Sanghatana'. A report detailing the matter was presented to Principal Secretary, Health, L.V. Subramanyam on Monday. The study reveals the appalling conditions prevalent at the teaching hospitals at Petla Burz and Koti, which are frequented by poor pregnant women from Old...

-IPS News THIRUVANANTHAPURAM: Balakrishnan, a labourer from Kochi in the southern Indian state of Kerala, was suffering from oral cancer. He was admitted to the Regional Cancer Centre (RCC) in Thiruvananthapuram. After the first course of radiation therapy, the 60-year-old could not eat or drink because of severe pain and infection in the mouth. An Ayurvedic mouth wash developed from the Neem plant was administered to Balakrishnan for three weeks during the...

-IPS News PESHAWAR, Pakistan- They are contraband, yet a large number of Pakistanis have come to depend on drugs made in India and smuggled into Pakistan. Patients as well as doctors say these are cheap and effective, even as law enforcers look the other way. The two countries do not have a trade agreement on drugs, but markets in Khyber Pakhtunkhwa province in the north of Pakistan do brisk business in India-made...

-The Indian Express India's role in pharmaceutical patent wars has broadened access to healthcare. Recently, there were rumours that the United States Trade Representative (USTR) was getting ready to announce "trade enforcement actions" or sanctions against India over its intellectual property rights regime. The Obama administration has been under pressure from the US Chamber of Commerce and lobby groups, like the Pharmaceutical Research and Manufacturers of America, to take a tough stance...